FDA chief counsel who defended abortion pill under Biden resigns 2 days into job
Recently selected Food and Drug Administration chief lawyer, Hilary K. Perkins, has resigned from the job, according to a ...
Recall issued for herbal powders sold in CT, NY, NJ and CA
A recall has been issued for Zaarah Herbals powders after an investigation in Connecticut found significantly elevated levels ...
Medscape3h
The End of Compounded GLP-1s: What Physicians Need to Know
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
Drugmakers Mallinckrodt, Endo in talks to merge, source says
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
FDA fights ultraprocessed foods
Bill Burr recently appeared on NPR’s “Fresh Air” to promote his new Hulu comedy special, “Drop Dead Years,” and he ripped not ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
UFlex receives FDA approval for recycled polyethylene in food packaging
The move marks an advancement in reducing plastic waste and assisting global brands in achieving their sustainability ...
Medical Device Network2h
Nearly a third of FDA medical device adverse event reports filed late
A study has found that nearly a third of medical device AEs were reported by manufacturers later than FDA's required 30-day ...
The free‑living bureaucrat
Michael Lewis on Heather Stone of the Food and Drug Administration.
Supplements Recalled Over Lead, Arsenic Concerns
Zaarah Herbals’ Rasayan Churan, Gurmar Powder, Vasaka Powder, and Bhringraj Powder recalled in four states due to potential ...
Dyne: Accelerated Approval Of DYNE-101 Might Be Possible With Surrogate Biomarker
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
The Manila Times20m
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury ...